56 related articles for article (PubMed ID: 22153824)
1. Fibroblast growth factor 23 and CKD prognosis.
Tangri N; Levey AS
Am J Kidney Dis; 2012 May; 59(5):607-10. PubMed ID: 22153824
[No Abstract] [Full Text] [Related]
2. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
[TBL] [Abstract][Full Text] [Related]
3. Regulation of fibroblast growth factor-23 in chronic kidney disease.
Westerberg PA; Linde T; Wikström B; Ljunggren O; Stridsberg M; Larsson TE
Nephrol Dial Transplant; 2007 Nov; 22(11):3202-7. PubMed ID: 17567652
[TBL] [Abstract][Full Text] [Related]
4. Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence.
Deniz ML; Kiliç T; Almaata I; Kurtkaya O; Sav A; Pamir MN
Neurosurgery; 2002 Sep; 51(3):753-60; discussion 760. PubMed ID: 12188955
[TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor receptors and their prognostic value in human breast cancer.
Blanckaert VD; Hebbar M; Louchez MM; Vilain MO; Schelling ME; Peyrat JP
Clin Cancer Res; 1998 Dec; 4(12):2939-47. PubMed ID: 9865904
[TBL] [Abstract][Full Text] [Related]
6. Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival.
Takanami I; Tanaka F; Hashizume T; Kodaira S
Neoplasma; 1997; 44(5):295-8. PubMed ID: 9473788
[TBL] [Abstract][Full Text] [Related]
7. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma.
Ueki T; Koji T; Tamiya S; Nakane PK; Tsuneyoshi M
J Pathol; 1995 Dec; 177(4):353-61. PubMed ID: 8568589
[TBL] [Abstract][Full Text] [Related]
8. Correlation of basic fibroblast growth factor expression with the invasion and the prognosis of oral squamous cell carcinoma.
Hase T; Kawashiri S; Tanaka A; Nozaki S; Noguchi N; Kato K; Nakaya H; Nakagawa K
J Oral Pathol Med; 2006 Mar; 35(3):136-9. PubMed ID: 16454808
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and basic fibroblast growth factor expression positively correlates with angiogenesis and peritumoural brain oedema in astrocytoma.
Jang FF; Wei W; De WM
J Ayub Med Coll Abbottabad; 2008; 20(2):105-9. PubMed ID: 19385471
[TBL] [Abstract][Full Text] [Related]
10. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer.
West AF; O'Donnell M; Charlton RG; Neal DE; Leung HY
Br J Cancer; 2001 Aug; 85(4):576-83. PubMed ID: 11506499
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia.
Xu X; Li J; Simons M; Li J; Laham RJ; Sellke FW
J Thorac Cardiovasc Surg; 2001 Apr; 121(4):735-42. PubMed ID: 11279416
[TBL] [Abstract][Full Text] [Related]
12. What would we like to know, and what do we not know about fibroblast growth factor 23?
Cozzolino M; Galassi A; Apetrii M; Covic A
J Nephrol; 2011; 24(6):696-706. PubMed ID: 21786227
[TBL] [Abstract][Full Text] [Related]
13. [Expression and clinical significance of Endostatin, vascular endothelial growth factor and fibroblast growth factor basic-2 in laryngeal carcinoma].
Liu WW; Zhang SJ; Han GH; Shi HJ; Wang JG; Dong SL; Li HX; Li GL; Sun QF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):687-91. PubMed ID: 18051571
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of cyclin D1, fibroblast growth factor receptor 3, and p53 immunohistochemistry in plasma cell myeloma treated with a thalidomide-based regimen.
Kelley TW; Baz R; Hussein M; Karafa M; Cook JR
Hum Pathol; 2009 Mar; 40(3):405-12. PubMed ID: 19070887
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of insulin like growth factor-1 (IGF-1) in children with different stages of chronic renal failure.
Derakhshan A; Karamifar H; Razavi Nejad SM; Fallahzadeh MH; Hashemi GH
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):173-6. PubMed ID: 17496390
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
[TBL] [Abstract][Full Text] [Related]
18. Prognosis in diabetic patients with acute myocardial infarction treated invasively is related to renal function.
Kowalczyk J; Lenarczyk R; Strojek K; Zielinska T; Gumprecht J; Sedkowska A; Kukulski T; Swierad M; Kowalski O; Sredniawa B; Polonski L; Zembala M; Kalarus Z
Med Sci Monit; 2010 Feb; 16(2):CR67-74. PubMed ID: 20110917
[TBL] [Abstract][Full Text] [Related]
19. Growth in chronic kidney disease.
Janjua HS; Mahan JD
Adv Chronic Kidney Dis; 2011 Sep; 18(5):324-31. PubMed ID: 21896373
[TBL] [Abstract][Full Text] [Related]
20. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
